Semax

What Is Semax?

Semax is a synthetic heptapeptide derived from the ACTH(4–10) fragment of adrenocorticotropic hormone. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it has been used clinically in Russia since the 1990s for cognitive disorders, stroke recovery, and optic nerve disease.

Unlike stimulant-based nootropics, Semax works by modulating neurotrophic factors–primarily brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). It does not produce the jitteriness, tolerance buildup, or crash associated with stimulants, making it a subject of growing research interest in cognitive optimization.

Mechanism of Action

Semax’s cognitive effects stem from its influence on neurotrophic signaling, neurotransmitter systems, and cerebral blood flow.

Key Pathways

• BDNF Upregulation: Significantly increases brain-derived neurotrophic factor expression, promoting neuronal survival, synaptic plasticity, and long-term memory consolidation.
• NGF Enhancement: Elevates nerve growth factor levels, supporting the maintenance and repair of cholinergic neurons critical for attention and learning.
• Dopamine & Serotonin Modulation: Influences dopaminergic and serotonergic turnover in the brain, contributing to improved focus, mood stability, and motivation.
• Cerebral Blood Flow: Enhances microcirculation in brain tissue, improving oxygen and glucose delivery to active neural networks.
• Neuroprotection: Reduces oxidative stress and excitotoxicity in neurons, offering protective effects during ischemic or neurodegenerative conditions.

Research Applications

Cognitive Enhancement

Semax is most commonly researched for its effects on memory, learning speed, and mental clarity. Its BDNF-driven mechanism supports both short-term working memory and long-term memory consolidation without stimulant side effects.

Stroke & Ischemic Recovery

Clinical use in Russia includes treatment of ischemic stroke. Research shows Semax may reduce infarct volume and improve functional outcomes when administered during or shortly after cerebral ischemic events.

ADHD & Attention

Preliminary research suggests Semax may improve attentional performance through its dopaminergic modulation, making it a subject of interest for attention-deficit conditions as a non-stimulant alternative.

Anxiety & Mood

Semax has demonstrated anxiolytic properties in animal models without sedation. Its serotonergic activity may contribute to mood stabilization, though human data outside of Russian clinical practice remains limited.

Dosing Protocol

Semax is typically administered intranasally. Its short half-life (~30 minutes) necessitates multiple daily doses for sustained effect, though its neurotrophic benefits accumulate over multi-week protocols.

How to Use

Nasal Administration

1. Clear nasal passages before use
2. Prime the spray if using for the first time (1–2 test pumps)
3. Insert tip into one nostril, angled slightly outward
4. Press down firmly for one spray while inhaling gently
5. Alternate nostrils between doses

Storage

• Refrigerate after opening (2–8°C / 36–46°F)
• Use within 4–6 weeks of opening
• Keep away from direct sunlight and heat